申请人:TAKEDA PHARMACEUTICAL COMPANY LIMITED
公开号:US20160185752A1
公开(公告)日:2016-06-30
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof (Formula (I)) in which m, X, R
1
, R
2
, R
3
and R
5
are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
本发明提供公式(I)的化合物及其药学上可接受的盐(公式(I)),其中m、X、R1、R2、R3和R5如规范中所定义,其制备过程、包含它们的制药组合物以及它们在治疗中的应用。